Pharmaceutical Glass Packaging Market Size, Share and Growth Report (2025-2030)

Market Overview

The Pharmaceutical Glass Packaging Market is witnessing steady growth due to increasing pharmaceutical production volumes and the continued preference for inert and contamination-resistant primary packaging solutions. The market benefits from the rising adoption of injectable drug formulations, including vaccines, biologics, and biosimilars, which require packaging materials capable of maintaining drug stability and sterility over extended periods. Glass packaging remains the preferred choice because of its chemical inertness, excellent barrier properties, and strong regulatory acceptance.

Request Sample Link: https://packagingmarketinsights.com/report/pharmaceutical-glass-packaging-market/request-sample

Manufacturers continue to focus on product standardization, compliance with pharmacopeial requirements, and enhanced container integrity to meet stringent regulatory standards. The growing transition toward high-quality molded and tubular glass solutions further supports market expansion across multiple therapeutic categories.

Market Size and Forecast

The global pharmaceutical glass packaging market size was valued at approximately USD 15.8 billion in 2024. The market is projected to grow from around USD 17.05 billion in 2025 to nearly USD 24.93 billion by 2030, registering a CAGR of about 7.9% during the forecast period from 2025 to 2030.

Growth is supported by increasing demand for safe pharmaceutical packaging solutions, expanding injectable drug production, and rising adoption of biologics and biosimilars worldwide. Regulatory emphasis on packaging safety and compatibility continues to reinforce market growth.

Market Drivers

Expanding Injectable and Biologic Drug Pipeline

The increasing development and commercialization of injectable therapies is a major driver of the pharmaceutical glass packaging market. Injectable drugs require packaging solutions that ensure sterility, stability, and long shelf life, making glass containers the preferred option across therapeutic areas such as oncology, immunology, and endocrinology.

Stringent Regulatory Requirements for Drug Packaging

Global regulatory authorities continue to emphasize packaging integrity, material safety, and compatibility testing. Pharmaceutical glass packaging fulfills these requirements due to its inert nature and established compliance history. The need to meet pharmacopeial standards across multiple geographies further strengthens demand for glass packaging solutions.

Market Challenges

Fragility and Breakage Risks in Glass Packaging

Despite its advantages, pharmaceutical glass packaging faces challenges related to fragility and breakage. Glass containers are vulnerable to cracks, delamination, and damage during transportation and storage. These issues can increase operational costs due to product loss, additional quality inspections, and secondary packaging requirements.

The need for specialized handling procedures and protective logistics solutions may limit adoption in certain high-volume and cost-sensitive pharmaceutical applications.

Market Opportunities

Growth in Emerging Pharmaceutical Manufacturing Hubs

Rapid expansion of pharmaceutical manufacturing capacities in emerging economies is creating significant opportunities for pharmaceutical glass packaging suppliers. Investments in domestic drug production facilities are increasing demand for packaging solutions that meet international quality and regulatory standards.

Technological Advancements in Glass Strengthening

Innovations in glass strengthening technologies, including advanced surface treatments and improved annealing processes, are enhancing container durability. These developments are expected to reduce breakage rates and broaden the use of glass packaging in high-speed pharmaceutical filling operations.

Market Segmentation

By Product Type

The vials segment dominated the pharmaceutical glass packaging market with a 41.2% share in 2024. Extensive use in packaging vaccines, antibiotics, biologics, and other injectable drugs contributed to its leadership position. Vials provide excellent chemical resistance, dosage accuracy, and compatibility with automated filling systems.

The cartridges segment is projected to grow at the fastest CAGR of 8.9% from 2025 to 2030. Growth is supported by increasing adoption of pen injectors for chronic disease management and the rising demand for self-administration therapies.

Other product type segments include:

• Ampoules

• Bottles

• Syringes

By Glass Type

Type I borosilicate glass held the largest market share of 54.7% in 2024 due to its superior chemical inertness, thermal resistance, and compatibility with sensitive drug formulations.

Type II treated soda-lime glass is expected to grow at the fastest CAGR of 8.3% during the forecast period, driven by its cost-efficiency and suitability for buffered and acidic formulations.

Additional glass type segments include:

• Type III Soda-Lime Glass

By Drug Type

Injectable drugs accounted for a leading 62.5% market share in 2024. The segment benefits from growing demand for sterile and long-lasting packaging solutions required for parenteral drug delivery.

Biologics and biosimilars are projected to register the highest CAGR of 9.1% between 2025 and 2030 due to expanding biologic pipelines and increasing biosimilar approvals globally.

Other drug type segments include:

• Oral Liquid Drugs

By End Use

Pharmaceutical manufacturers represented the largest end-use segment, accounting for 68.9% of the market in 2024. Direct procurement of glass packaging enables greater quality control and supply chain reliability.

Contract Manufacturing Organizations (CMOs) are expected to grow at the fastest CAGR of 8.5% during the forecast period, supported by increasing outsourcing of pharmaceutical production.

Regional Analysis

Asia Pacific

Asia Pacific accounted for approximately 38.6% of the global market share in 2024 and represented about 39.2% in 2025. The region is expected to record the fastest growth at a CAGR of 8.6%. Expansion of pharmaceutical manufacturing facilities and increasing healthcare expenditure continue to drive regional demand.

China leads the regional market due to large-scale pharmaceutical production, expanding vaccine manufacturing, and supportive government initiatives.

North America

North America accounted for approximately 31.4% of the pharmaceutical glass packaging market share in 2025 and is projected to grow at a CAGR of 6.8%. Growth is supported by a mature pharmaceutical industry, strong regulatory oversight, and widespread adoption of injectable therapies.

The United States dominated the regional market and recorded a market value of USD 3.9 billion in 2024, increasing to an estimated USD 4.2 billion in 2025.

Europe

Europe held nearly 27.6% of the global market share in 2025 and is expected to expand at a CAGR of 6.5%. The region benefits from established pharmaceutical manufacturing clusters and strict packaging regulations focused on safety and traceability.

Germany emerged as the leading market within the region.

Middle East & Africa

The Middle East & Africa accounted for 6.1% of the global market share in 2025 and is projected to grow at a CAGR of 6.9%. Investments in healthcare infrastructure and pharmaceutical manufacturing continue to support growth.

Saudi Arabia remains the dominant market in the region.

Latin America

Latin America held approximately 5.7% of the market share in 2025 and is expected to expand at a CAGR of 6.7%. Growth is supported by increasing healthcare access and expanding pharmaceutical production capabilities.

Brazil emerged as the leading country in the region.

Key Players

The pharmaceutical glass packaging market is moderately consolidated, with companies competing through product quality, regulatory compliance, manufacturing capacity, and supply reliability.

Key players operating in the market include:

1. SCHOTT AG

2. Gerresheimer AG

3. Corning Incorporated

4. SGD Pharma

5. Nipro Corporation

6. Stevanato Group

7. Ardagh Group

8. West Pharmaceutical Services

SCHOTT AG emerged as a market leader due to its broad portfolio of pharmaceutical glass solutions and investments in advanced borosilicate glass production technologies.

Conclusion

The Pharmaceutical Glass Packaging Market is expected to experience robust growth through 2030, supported by increasing injectable drug production, expanding biologics and biosimilars pipelines, and stringent regulatory requirements for pharmaceutical packaging. The market continues to benefit from the superior performance characteristics of glass packaging, including chemical inertness, product stability, and compliance with global quality standards.

Growing pharmaceutical manufacturing activities in emerging economies, coupled with advancements in glass strengthening technologies, are expected to create substantial opportunities for market participants. As demand for safe and reliable pharmaceutical packaging continues to increase, the pharmaceutical glass packaging market is positioned for sustained long-term growth.

Report Link: https://packagingmarketinsights.com/report/pharmaceutical-glass-packaging-market